Organization WH (2017) Global hepatitis report 2017. Geneva: World Health Organization
Centers for Disease Control and Prevention (CDC) (2012) Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012. MMWR Morb Mortal Wkly Rep 61(29):545–9.
Waked I, Esmat G, Elsharkawy A, El-Serafy M, Abdel-Razek W, Ghalab R et al (2020) Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med 382(12):1166–1174. https://doi.org/10.1056/NEJMsr1912628
Article
PubMed
Google Scholar
Cresci GA, Bawden E (2015) Gut microbiome: what we do and don’t know. Nutr Clin Pract 30(6):734–746. https://doi.org/10.1177/0884533615609899
Article
CAS
PubMed
PubMed Central
Google Scholar
Dzutsev A, Badger JH, Perez-Chanona E, Roy S, Salcedo R, Smith CK, Trinchieri G (2017) Microbes and cancer. Annu Rev Immunol 35(1):199–228. https://doi.org/10.1146/annurev-immunol-051116-052133
Article
CAS
PubMed
Google Scholar
Shahanavaj K, Gil-Bazo I, Castiglia M, Bronte G, Passiglia F, Carreca AP, del Pozo JL, Russo A, Peeters M, Rolfo C (2015) Cancer and the microbiome: potential applications as new tumor biomarker. Expert Rev Anticancer Ther 15(3):317–330. https://doi.org/10.1586/14737140.2015.992785
Article
CAS
PubMed
Google Scholar
Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123. https://doi.org/10.1126/science.1224820
Article
CAS
PubMed
PubMed Central
Google Scholar
Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M et al (2015) Cancer and the gut microbiota: an unexpected link. Sci Transl Med 7(271):271ps1-ps1
Article
Google Scholar
Yu L-X, Schwabe RF (2017) The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 14(9):527–539. https://doi.org/10.1038/nrgastro.2017.72
Article
PubMed
PubMed Central
Google Scholar
Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA (2019) The microbiome, cancer, and cancer therapy. Nat Med 25(3):377–388. https://doi.org/10.1038/s41591-019-0377-7
Article
CAS
PubMed
Google Scholar
Morkūnas E, Skiecevičienė J, Kupčinskas J (2020) The impact of modulating the gastrointestinal microbiota in cancer patients. Best Pract Res Clin Gastroenterol 101700:101700. https://doi.org/10.1016/j.bpg.2020.101700
Article
Google Scholar
Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G (2017) Anticancer effects of the microbiome and its products. Nat Rev Microbiol 15(8):465–478. https://doi.org/10.1038/nrmicro.2017.44
Article
CAS
PubMed
Google Scholar
Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L (2016) Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 45(4):931–943. https://doi.org/10.1016/j.immuni.2016.09.009
Article
CAS
PubMed
Google Scholar
Gensollen T, Iyer SS, Kasper DL, Blumberg RS (2016) How colonization by microbiota in early life shapes the immune system. Science. 352(6285):539–544. https://doi.org/10.1126/science.aad9378
Article
CAS
PubMed
PubMed Central
Google Scholar
Guarner F, Malagelada J-R (2003) Gut flora in health and disease. Lancet 361(9356):512–519. https://doi.org/10.1016/S0140-6736(03)12489-0
Article
PubMed
Google Scholar
Natividad JMM, Verdu EF (2013) Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res 69(1):42–51. https://doi.org/10.1016/j.phrs.2012.10.007
Article
CAS
PubMed
Google Scholar
den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325–2340. https://doi.org/10.1194/jlr.R036012
Article
CAS
Google Scholar
Bäumler AJ, Sperandio V (2016) Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 535(7610):85–93. https://doi.org/10.1038/nature18849
Article
CAS
PubMed
PubMed Central
Google Scholar
Acharya C, Sahingur SE, Bajaj JS (2017) Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight 2(19):e94416. https://doi.org/10.1172/jci.insight.94416
Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP (2016) Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol 8(27):1128–1136. https://doi.org/10.4254/wjh.v8.i27.1128
Article
PubMed
PubMed Central
Google Scholar
Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383(9930):1749–1761
Article
Google Scholar
Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K, Iio E, Nojiri S, Fujiwara K, Yoneda M, Yoshiji H, Tanaka Y (2018) Gut dysbiosis associated with hepatitis C virus infection. Clin Infect Dis 67(6):869–877. https://doi.org/10.1093/cid/ciy205
Article
CAS
PubMed
Google Scholar
Darnaud M, Faivre J, Moniaux N (2013) Targeting gut flora to prevent progression of hepatocellular carcinoma. J Hepatol 58(2):385–387. https://doi.org/10.1016/j.jhep.2012.08.019
Article
PubMed
Google Scholar
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649. https://doi.org/10.1002/bjs.1800600817
Article
CAS
PubMed
Google Scholar
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391(10127):1301–1314. https://doi.org/10.1016/S0140-6736(18)30010-2
Article
PubMed
Google Scholar
Nadkarni MA, Martin FE, Jacques NA, Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148(Pt 1):257–266
Article
CAS
Google Scholar
Collado MC, Derrien M, Isolauri E, de Vos WM, Salminen S (2007) Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 73(23):7767–7770. https://doi.org/10.1128/AEM.01477-07
Article
CAS
PubMed
PubMed Central
Google Scholar
Bergström A, Licht TR, Wilcks A, Andersen JB, Schmidt LR, Grønlund HA, Vigsnaes LK, Michaelsen KF, Bahl MI (2012) Introducing GUt low-density array (GULDA): a validated approach for qPCR-based intestinal microbial community analysis. FEMS Microbiol Lett 337(1):38–47. https://doi.org/10.1111/1574-6968.12004
Article
CAS
PubMed
Google Scholar
Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97(6):1166–1177. https://doi.org/10.1111/j.1365-2672.2004.02409.x
Article
CAS
PubMed
Google Scholar
Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101(4):541–550. https://doi.org/10.1017/S0007114508019880
Article
CAS
PubMed
Google Scholar
Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D (2015) Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138:179–187. https://doi.org/10.1016/j.physbeh.2014.10.033
Article
CAS
PubMed
Google Scholar
Shannon CE (1948) A mathematical theory of communication. Bell Sys Techn J 27(3):379–423. https://doi.org/10.1002/j.1538-7305.1948.tb01338.x
Article
Google Scholar
Bray JR, Curtis JT (1957) An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr 27(4):325–349. https://doi.org/10.2307/1942268
Article
Google Scholar
Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A et al (2016) Hepatocellular carcinoma: a review. J Hepatocellular Carcinoma 3:41–53. https://doi.org/10.2147/JHC.S61146
Article
Google Scholar
Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D et al (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562–572
Article
Google Scholar
Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, Noble NA, Unser AB, Daita K, Fisher AR, Sikaroodi M, Gillevet PM (2014) Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 60(5):940–947. https://doi.org/10.1016/j.jhep.2013.12.019
Article
CAS
PubMed
Google Scholar
Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut JP, Kan Q, Li L, Zheng S (2019) Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 68(6):1014–1023. https://doi.org/10.1136/gutjnl-2017-315084
Article
CAS
PubMed
Google Scholar
Zheng R, Wang G, Pang Z, Ran N, Gu Y, Guan X, Yuan Y, Zuo X, Pan H, Zheng J, Wang F (2020) Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma. Cancer Med 9(12):4232–4250. https://doi.org/10.1002/cam4.3045
Article
CAS
PubMed
PubMed Central
Google Scholar
Gérard P (2013) Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens. 3(1):14–24. https://doi.org/10.3390/pathogens3010014
Article
CAS
PubMed
PubMed Central
Google Scholar
Piñero F, Vazquez M, Baré P, Rohr C, Mendizabal M, Sciara M, Alonso C, Fay F, Silva M (2019) A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma. Ann Hepatol 18(3):480–487. https://doi.org/10.1016/j.aohep.2018.10.003
Article
CAS
PubMed
Google Scholar
Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F et al (2019) Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69(1):107–120
Article
CAS
Google Scholar
Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK (2016) Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog 8(1):42. https://doi.org/10.1186/s13099-016-0124-2
Article
CAS
PubMed
PubMed Central
Google Scholar
Sydor S, Best J, Messerschmidt I, Manka P, Vilchez-Vargas R, Brodesser S et al (2020) Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clin Transl Gastroenterol 11(3):e00131-e
Article
Google Scholar
Wu Y-N, Zhang L, Chen T, Li X, He L-H, Liu G-X (2020) Granulocyte-macrophage colony-stimulating factor protects mice against hepatocellular carcinoma by ameliorating intestinal dysbiosis and attenuating inflammation. World J Gastroenterol 26(36):5420–5436. https://doi.org/10.3748/wjg.v26.i36.5420
Article
CAS
PubMed
PubMed Central
Google Scholar
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR et al (2011) Enterotypes of the human gut microbiome. Nature. 473(7346):174–180. https://doi.org/10.1038/nature09944
Article
CAS
PubMed
PubMed Central
Google Scholar
Thorburn Alison N, Macia L, Mackay CR (2014) Diet, metabolites, and “Western-Lifestyle” inflammatory diseases. Immunity. 40(6):833–842. https://doi.org/10.1016/j.immuni.2014.05.014
Article
CAS
PubMed
Google Scholar
Chen W, Wang S, Wu Y, Shen X, Guo Z, Li Q, Xing D (2020) Immunogenic cell death: a link between gut microbiota and anticancer effects. Microb Pathog 141:103983. https://doi.org/10.1016/j.micpath.2020.103983
Article
CAS
PubMed
Google Scholar
Yamamoto K, Kuzuya T, Honda T, Ito T, Ishizu Y, Nakamura M et al (2020) Relationship between adverse events and microbiomes in advanced hepatocellular carcinoma patients treated with sorafenib. Anticancer Res 40(2):665–676. https://doi.org/10.21873/anticanres.13996
Article
CAS
PubMed
Google Scholar